Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Andrade-Campos
Results of Phase Ii Study of Combined Immunotherapy With Rituximab Plus Lymphokine-Activated Killer Cells as Maintenance in Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Patients With Follicular Lymphoma (Fl) in Maintained Complete Response (Cr) at 30 Months Show a Survival Similar to a Sex- And Age-Matched Spanish General Population
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study
British Journal of Haematology
Hematology
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients With Relapsed B-Cell Lymphoma Treated With Rituximab
Clinical Cancer Research
Cancer Research
Oncology
Imaging Pattern of Radiolabelled Lymphokine-Activated Killer Cells in Patients With Metastatic Malignant Melanoma
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Effect of Adherent Cells on Induction of Lymphokine-Activated Killer Cells: Study in Patients With Hepatocellular Carcinoma and Liver Cirrhosis.
Japanese Journal of Clinical Immunology
Generation of Adherent Lymphokine Activated Killer (A-Lak) Cells From Patients With Acute Myelogenous Leukaemia
British Journal of Cancer
Cancer Research
Oncology
A Retrospective Study on the Management of Patients With Rituximab Refractory Follicular Lymphoma
British Journal of Haematology
Hematology
